537 related articles for article (PubMed ID: 8811061)
1. Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
[TBL] [Abstract][Full Text] [Related]
2. Oral tolerance in experimental autoimmune encephalomyelitis.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Ann N Y Acad Sci; 1996 Feb; 778():217-27. PubMed ID: 8610975
[TBL] [Abstract][Full Text] [Related]
3. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
Meyer AL; Benson JM; Gienapp IE; Cox KL; Whitacre CC
J Immunol; 1996 Nov; 157(9):4230-8. PubMed ID: 8892661
[TBL] [Abstract][Full Text] [Related]
4. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
[TBL] [Abstract][Full Text] [Related]
5. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
6. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
Javed NH; Gienapp IE; Cox KL; Whitacre CC
J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
[TBL] [Abstract][Full Text] [Related]
7. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
[TBL] [Abstract][Full Text] [Related]
8. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
[TBL] [Abstract][Full Text] [Related]
9. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
Jewell SD; Gienapp IE; Cox KL; Whitacre CC
Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
[TBL] [Abstract][Full Text] [Related]
10. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
Whitacre CC; Gienapp IE; Orosz CG; Bitar DM
J Immunol; 1991 Oct; 147(7):2155-63. PubMed ID: 1717550
[TBL] [Abstract][Full Text] [Related]
11. Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens.
Maassen CB; Laman JD; van Holten-Neelen C; Hoogteijling L; Groenewegen L; Visser L; Schellekens MM; Boersma WJ; Claassen E
Vaccine; 2003 Dec; 21(32):4685-93. PubMed ID: 14585676
[TBL] [Abstract][Full Text] [Related]
12. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
[TBL] [Abstract][Full Text] [Related]
13. Resistance to experimental autoimmune encephalomyelitis induced by neonatal tolerization to myelin basic protein: clonal elimination vs. regulation of autoaggressive lymphocytes.
Qin YF; Sun DM; Goto M; Meyermann R; Wekerle H
Eur J Immunol; 1989 Feb; 19(2):373-80. PubMed ID: 2467819
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
Tan LJ; Vanderlugt CL; McRae BL; Miller SD
Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
16. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
Wang ZY; He B; Qiao J; Link H
J Neuroimmunol; 1995 Dec; 63(1):79-86. PubMed ID: 8557828
[TBL] [Abstract][Full Text] [Related]
17. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
Khoury SJ; Hancock WW; Weiner HL
J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385
[TBL] [Abstract][Full Text] [Related]
18. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
[TBL] [Abstract][Full Text] [Related]
19. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine influences on experimental autoimmune encephalomyelitis.
Whitacre CC; Dowdell K; Griffin AC
Ann N Y Acad Sci; 1998 May; 840():705-16. PubMed ID: 9629297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
